Cite
MLA Citation
Ahmed O. Kaseb et al.. “Modified cisplatin/interferon α‐2b/doxorubicin/5‐fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma.” Cancer, vol. 119, no. 18, 2013, pp. 3334–3342. http://access.bl.uk/ark:/81055/vdc_100025043991.0x00003e